ChampionX Co. (NASDAQ:CHX – Get Free Report) was the target of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 7,810,000 shares, a drop of 10.4% from the March 15th total of 8,720,000 shares. Approximately 4.1% of the company’s shares are sold short. Based on an average trading volume of 2,010,000 shares, the days-to-cover ratio is presently 3.9 days.
ChampionX Stock Down 0.8 %
CHX stock traded down $0.30 during mid-day trading on Tuesday, reaching $36.64. The company had a trading volume of 1,637,968 shares, compared to its average volume of 2,007,428. ChampionX has a 52 week low of $24.98 and a 52 week high of $39.95. The company has a market capitalization of $7.00 billion, a price-to-earnings ratio of 23.34, a PEG ratio of 1.18 and a beta of 2.44. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.82 and a quick ratio of 1.15. The stock has a 50 day simple moving average of $33.27 and a two-hundred day simple moving average of $31.07.
ChampionX (NASDAQ:CHX – Get Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The business had revenue of $943.56 million for the quarter, compared to the consensus estimate of $947.33 million. ChampionX had a net margin of 8.36% and a return on equity of 20.14%. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.43 earnings per share. As a group, equities analysts predict that ChampionX will post 1.95 earnings per share for the current fiscal year.
ChampionX Increases Dividend
Insider Buying and Selling
In other news, insider William Jr. O’dell sold 27,178 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $36.00, for a total value of $978,408.00. Following the completion of the transaction, the insider now owns 57,748 shares of the company’s stock, valued at approximately $2,078,928. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.38% of the stock is owned by insiders.
Institutional Trading of ChampionX
A number of hedge funds have recently made changes to their positions in CHX. BlackRock Inc. raised its stake in ChampionX by 0.5% in the 1st quarter. BlackRock Inc. now owns 24,501,257 shares of the company’s stock valued at $599,791,000 after acquiring an additional 126,529 shares during the period. Vanguard Group Inc. lifted its stake in shares of ChampionX by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,033,091 shares of the company’s stock worth $585,167,000 after buying an additional 62,967 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of ChampionX by 13.7% during the 2nd quarter. Alliancebernstein L.P. now owns 8,184,487 shares of the company’s stock worth $254,046,000 after buying an additional 988,872 shares during the period. State Street Corp grew its stake in ChampionX by 6.1% in the 1st quarter. State Street Corp now owns 7,422,065 shares of the company’s stock valued at $201,357,000 after buying an additional 426,656 shares during the last quarter. Finally, FMR LLC raised its holdings in ChampionX by 20.2% in the 3rd quarter. FMR LLC now owns 7,109,432 shares of the company’s stock valued at $253,238,000 after acquiring an additional 1,193,122 shares during the period. 98.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on CHX. Piper Sandler boosted their price target on ChampionX from $32.00 to $40.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Barclays upped their price target on ChampionX from $39.00 to $51.00 and gave the stock an “overweight” rating in a research report on Thursday, April 4th. Finally, Citigroup boosted their price objective on shares of ChampionX from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Wednesday, March 27th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $40.33.
Get Our Latest Stock Analysis on ChampionX
ChampionX Company Profile
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Featured Articles
- Five stocks we like better than ChampionX
- What is a Secondary Public Offering? What Investors Need to Know
- Silicon Motion Proves That AI in Motion Stays in Motion
- What Are Dividend Challengers?
- Undervalued UnitedHealth Group Won’t Be For Long
- Learn Technical Analysis Skills to Master the Stock Market
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for ChampionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChampionX and related companies with MarketBeat.com's FREE daily email newsletter.